ADVISORY COUNCIL REVIEW OF RARE DISEASE BILLS.

Printer-friendly: Click to view
View NCGA Bill Details2017-2018 Session
House Bill 808 (Public) Filed Tuesday, April 11, 2017
AN ACT EXPANDING THE DUTIES OF THE ADVISORY COUNCIL ON RARE DISEASES TO INCLUDE THE PREPARATION OF OPINIONS ON PROPOSED BILLS AND RESOLUTIONS PERTAINING TO RARE DISEASES AND REQUIRING THE OPINIONS TO BE PROVIDED TO THE BILL SPONSOR.
Intro. by Carney, Dollar, Torbett, Adcock.

Status: Ref To Com On Rules and Operations of the Senate (Senate Action) (Apr 26 2017)

SOG comments (1):

Long Title Change

House committee substitute to the 1st edition changes the long title. The original is as follows:

AN ACT EXPANDING THE DUTIES OF THE ADVISORY COUNCIL ON RARE DISEASES TO INCLUDE THE PREPARATION OF ADVISORY NOTES FOR PROPOSED BILLS AND RESOLUTIONS PERTAINING TO RARE DISEASES AND REQUIRING THE ADVISORY NOTE TO BE ATTACHED TO THE BILL OR RESOLUTION AT THE TIME OF ITS CONSIDERATION BY THE GENERAL ASSEMBLY.

H 808

Bill Summaries:

  • Summary date: Apr 25 2017 - View Summary

    House committee substitute makes the following changes to the 1st edition.

    Amends proposed subdivision (3) in GS 130A-33.66, requiring the Advisory Council on Rare Diseases to review each proposed bill and resolution pertaining to rare diseases, rare disease research, or rare disease care and prepare an opinion  (previously, prepare an advisory note with an opinion) on the merits of the proposed bill or resolution and any recommended changes to the measure. Directs the Advisory Council to provide the opinion to the bill sponsor within 14 calendar days after receiving a copy of the proposed bill or resolution (previously, specified as prescribed by GS 120-30.55 and did not specify the opinion is to be provided to the bill sponsor).

    Deletes Section 2, enacting GS 120-30.55 (Advisory notes from the Advisory Council on Rare Diseases on legislation pertaining to rare diseases).

    Deletes Section 3, extending the terms of the current members of the Advisory Council on Rare Diseases until July 31, 2021.

    Deletes Section 4, appropriating funds to the Department of Health and Human Services to be allocated to the Advisory Council on Rare Diseases to prepare advisory notes for proposed bills and resolutions.

    Amends the act's long title.


  • Summary date: Apr 11 2017 - View Summary

    Identical to S 310, filed 3/16/17.

    Enacts new Article 6E, Review of Rare Disease Bills and Resolutions, in GS Chapter 120. Requires that every bill and resolution introduced in the General Assembly that proposes changes to the law pertaining to rare diseases, rare disease research, or rare disease care include an advisory note prepared by the Advisory Council on Rare Diseases (Advisory Council). Specifies that the advisory note must include the Advisory Council's opinion about the merits of the legislation and any recommended changes. Requires the Advisory Council to give the advisory note to the bill sponsor within two weeks after the sponsor has made the request for an advisory note, unless the sponsor agrees to more time. Requires that the advisory note be attached to the original of each proposed bill or resolution that is reported favorably by a committee, but specifies that the note is not a part of the legislation and is not an expression of legislative intent proposed by the legislation. Requires that if a committee reports favorably a proposed bill or resolution with an amendment that proposes a change in the law that pertains to rare diseases, rare disease research, or rare disease care, the chairperson of the committee must obtain an advisory note from the Advisory Council and attach it to the amended bill or resolution. Requires that copies the advisory notes be given to the sponsor of the bill or resolution and the chairpersons of the rules committees.

    Makes conforming changes toGS 130A-33.66 by adding the review of each proposed bill and resolution pertaining to rare diseases, rare disease research, and rare disease care and the preparation of an advisory note within 14 days to the Advisory Council's duties. 

    Appropriates $250,000 for 2017-18 and $250,000 for 2018-19 from the General Fund to the Department of Health and Human Services to be allocated to the Advisory Council to prepare advisory notes.

    Effective July 1, 2017.